Anti-CD38 Reference Antibody (felzartamab)
- Product Code: 139883
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in the treatment of multiple myeloma, this antibody targets CD38, a protein highly expressed on malignant plasma cells. It induces cell death through mechanisms like antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and direct apoptosis. Employed in clinical settings, especially for patients who are refractory to other therapies, it shows efficacy in reducing tumor burden and prolonging progression-free survival. Also investigated for use in autoimmune conditions and other CD38-positive hematologic malignancies.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-CD38 Reference Antibody (felzartamab)
Used in the treatment of multiple myeloma, this antibody targets CD38, a protein highly expressed on malignant plasma cells. It induces cell death through mechanisms like antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and direct apoptosis. Employed in clinical settings, especially for patients who are refractory to other therapies, it shows efficacy in reducing tumor burden and prolonging progression-free survival. Also investigated for use in autoimmune conditions and other CD38-positive hematologic malignancies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :